Door-to-needle times in acute ischemic stroke
暂无分享,去创建一个
[1] Atte Meretoja,et al. Reducing in-hospital delay to 20 minutes in stroke thrombolysis , 2012, Neurology.
[2] Eric E. Smith,et al. Improving Door-to-Needle Times in Acute Ischemic Stroke: The Design and Rationale for the American Heart Association/American Stroke Association's Target Stroke Initiative , 2011, Stroke.
[3] Dawn Kleindorfer,et al. Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States: A Doubling of Treatment Rates Over the Course of 5 Years , 2011, Stroke.
[4] Adrian F Hernandez,et al. Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic Stroke: Patient Characteristics, Hospital Factors, and Outcomes Associated With Door-to-Needle Times Within 60 Minutes , 2011, Circulation.
[5] Mark Parsons,et al. Implementation and outcome of thrombolysis with alteplase 3–4·5 h after an acute stroke: an updated analysis from SITS-ISTR , 2010, The Lancet Neurology.
[6] Gregory W Albers,et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials , 2010, The Lancet.
[7] R. Kummer. After European Cooperative Acute Stroke Study 3: Mission Accomplished? , 2009 .
[8] R. von Kummer,et al. After European Cooperative Acute Stroke Study 3: mission accomplished? , 2009, Stroke.
[9] A. Alexandrov,et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. , 2004, The New England journal of medicine.
[10] R E Latchaw,et al. Recommendations for the establishment of primary stroke centers , 2000 .